Cell and Gene Logistics

  1. The CDMO Pricing Playbook 7/27/2026

    Why do two CDMOs with identical direct costs quote prices 2.6x apart? Learn the three-element pricing framework, capacity utilization math, and market-based strategies that explain every RFQ surprise.

  2. Reshoring Pressure Meets Manufacturing Reality 7/27/2026

    U.S. pharma can't reshore what domestic capacity can't absorb. Senior leaders from Takeda, Biogen, Eli Lilly, and others reveal why tariff pressure is colliding with a sterile fill-finish shortage, workforce gaps, and ADC capacity bottlenecks.

  3. CDMO Live Europe 2026: Partnerships For An Uncertain World 7/27/2026

    112 pages of executive insight from CDMO Live Europe 2026: tariffs, geopolitics, supply resilience, AI in manufacturing, and why strategic partnerships remain aspirational for most.

  4. Resilience, Risk, And Relationships: CDMO Live Europe 2026 Report 7/27/2026

    Senior pharma leaders from Pfizer, Bayer, BioNTech and others debunk dual sourcing myths and reveal what separates strategic CDMO partnerships from transactional ones.

  5. The Missing Layer: Why CAR-T Needs AI As Its Connective Tissue 7/21/2026

    AI can close CAR-T’s access gap by replacing fragmented community delivery handoffs with automated orchestration across referral, reimbursement, logistics, and monitoring.

  6. Master Control Quality Excellence 6/30/2026

    An interconnected digital platform unifies quality documents, training, and corrective actions. Learn to eliminate manual gaps and use automated metrics to drive long-term operational excellence.

  7. Startup Decision Guide: Right-Size Your Life Science QMS 6/30/2026

    Evaluating quality frameworks requires balancing immediate compliance with long-term scalability. Learn to analyze organizational maturity and regulatory demands to select an optimal system.

  8. The Connectivity Crisis Blocking AI Deployment 6/30/2026

    Disconnected systems and siloed data block analytics in life sciences manufacturing. Learn to bridge the infrastructure gap and build a connected foundation for scalable intelligence.

  9. Mapping Early-Phase Supply Chain Bottlenecks That Doom Pipelines 6/30/2026

    Many sponsors miscast preclinical development as an unglamorous step between discovery and the clinic. Here's how the consequences may lead to irrevocable losses.

  10. From LAL To rFC: The Evolution Of Endotoxin Testing 6/26/2026

    Protect patient safety and ensure regulatory compliance by implementing sensitive, reliable bacterial endotoxin testing as a critical component of pharmaceutical quality assurance.